Dr. Gong is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4600 Scyene Rd
Dallas, TX 75210Phone+1 214-266-4000Fax+1 214-266-0113
Education & Training
- SUNY Downstate Health Sciences UniversityResidency, Pediatrics, 1995 - 1998
- Shanghai Medical UniversityClass of 1989
Certifications & Licensure
- TX State Medical License 2002 - 2026
- LA State Medical License 1998 - 2007
- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2012-2014
- Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2012-2014
- Fellow (FAAP) American Academy of Pediatrics
Clinical Trials
- Different Surgical Procedures of Peroral Endoscopic Myotomy(POEM) for Esophageal Achalasia Start of enrollment: 2016 Dec 01
Publications & Presentations
PubMed
- 30 citationsPre-treatment Eckardt score is a simple factor for predicting one-year peroral endoscopic myotomy failure in patients with achalasiaYutang Ren, Xiaowei Tang, Yanmin Chen, Fengping Chen, Yingying Zou
Surgical Endoscopy. 2017-08-01 - 16 citationsPeroral endoscopic shorter versus longer myotomy for the treatment of achalasia: a comparative retrospective studySilin Huang, Yutang Ren, Wei Peng, Qiaoping Gao, Yan Peng
Esophagus. 2020-05-02 - 19 citationsTFAM depletion overcomes hepatocellular carcinoma resistance to doxorubicin and sorafenib through AMPK activation and mitochondrial dysfunction.Ying Zhu, Jianguo Xu, Wei Hu, Fang Wang, Yan Zhou
Gene. 2020-08-30
Press Mentions
- STEMI Patients with in-Hospital Cardiac Arrest Bear Outsize Mortality BurdenOctober 31st, 2022
- DGCR5 Is Activated by PAX5 and Promotes Pancreatic Cancer via Targeting miR-3163/TOP2A and Activating Wnt/Β-catenin PathwayJanuary 1st, 2021
- DGCR5 Is Activated by PAX5 and Promotes Pancreatic Cancer via Targeting miR-3163/TOP2A and Activating Wnt/Β-catenin PathwayDecember 22nd, 2020
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: